Klara Schmidthaler

Ms. Klara Schmidthaler

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Allergy
Verified
Journal Article
Closed access
PDF file
JHJennifer A. Hoang
Jennifer A. Hoang
ACAlper Celik
Alper Celik
CLChristian Lupinek
Christian Lupinek
RVRudolf Valenta
Rudolf Valenta
LDLucy Duan
Lucy Duan
TEThomas Eiwegger
Thomas Eiwegger

8 April 2024 in Allergy
Verified
Journal Article
Open access
PDF file
VDVarsha Dwivedi
Varsha Dwivedi
SKSonja Kopanja
Sonja Kopanja
KSKlara Schmidthaler
Klara Schmidthaler
JSJustyna Sieber
Justyna Sieber
CBChristina Bannert
Christina Bannert
ZSZsolt Szepfalusi
Zsolt Szepfalusi
The efficacy and safety of preventive allergen immunotherapy (pAIT) in children are currently under investigation. Here, we provide an overview of pAIT with respiratory allergens concerning the prevention of new sensitizations, allergic disease onset and progression as well as further immunomodulatory effects. Three databases were searched for clinical pAIT studies in children. Selected publications were reviewed for preventive outcomes according to prevention level (primary, secondary, and tertiary), allergen type, administration route, dose, and treatment duration. The primary prevention approach appears safe but showed no allergen‐specific effect on new sensitizations. Secondary prevention seems feasible and may induce regulatory T cell‐mediated immunotolerance. The number of studies at these prevention levels is limited. Tertiary prevention with grass and/or tree pollen‐based pAIT has shown efficacy in preventing disease progression from allergic rhinitis/conjunctivitis to asthma. Data on tertiary pAIT with house dust mites and other allergen types are inconclusive. Subcutaneous and sublingual routes appear similarly effective, but head‐to‐head comparative paediatric studies are scarce. Additionally, there are fewer placebo‐controlled studies. Nevertheless, immunomodulatory outcomes of pAIT are encouraging. Currently, limited but favourably suggestive evidence is available for preventing respiratory allergic diseases in children by pAIT. Primary and secondary prevention have potential and warrant further investigation through well‐designed studies.

26 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
RFRaphaela Freidl
Raphaela Freidl
Victoria GaribVictoria Garib
Victoria Garib
BLBirgit Linhart
Birgit Linhart
EHElisabeth Haberl
Elisabeth Haberl
IMIsabelle Mader
Isabelle Mader
RVRudolf Valenta
Rudolf Valenta
Background: Immunoglobulin E (IgE)-mediated cow’s milk allergy (CMA) can be life-threatening and affects up to 3% of children. Hypoallergenic infant formulas based on hydrolyzed cow’s milk protein are increasingly considered for therapy and prevention of cow’s milk allergy. The aim of this study was to investigate the allergenic activity and ability to induce T cell and cytokine responses of an infant formula based on extensively hydrolyzed cow’s milk protein (whey) (eHF, extensively hydrolyzed formula) supplemented with Galactooligosaccharides (GOS) and Limosilactobacillus fermentum CECT5716 (LF) to determine its suitability for treatment and prevention of CMA. Methods: eHF and standard protein formula based on intact cow’s milk proteins (iPF) with or without Galactooligosaccharide (GOS) and Limosilactobacillus fermentum CECT5716 (LF) were investigated with allergen-specific antibodies and tested for IgE reactivity and allergenic activity in basophil degranulation assays with sera from cow’s milk (CM)-allergic infants/children. Their ability to stimulate T cell proliferation and cytokine secretion in cultured peripheral blood mononuclear cells (PBMC) from CM-allergic infants and children was studied with a FACS-based carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution assay and xMAP Luminex fluorescent bead-based technology, respectively. Results: An eHF supplemented with GOS and LF exhibiting almost no IgE reactivity and allergenic activity was identified. This eHF induced significantly lower inflammatory cytokine secretion as compared to an intact protein-based infant formula but retained T cell reactivity. Conclusions: Due to strongly reduced allergenic activity and induction of inflammatory cytokine secretion but retained T cell reactivity, the identified eHF may be used for treatment and prevention of CMA by induction of specific T cell tolerance.

25 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JSJustyna Sieber
Justyna Sieber
NMNicole Martin
Nicole Martin
KSKlara Schmidthaler
Klara Schmidthaler
RGRené Gaupmann
René Gaupmann
EDEleonora Dehlink
Eleonora Dehlink
SGSaskia Gruber
Saskia Gruber
Background/Objectives: Patients with chronic lung diseases, such as cystic fibrosis, were considered a risk group for a severe course of coronavirus disease 2019 at the beginning of the pandemic. However, mounting evidence suggests that this group may not face an elevated risk for a severe SARS-CoV-2 infection. Methods: Here, we present data on the incidence and clinical course of SARS-CoV-2 infections in a single pediatric CF centre in Austria. Clinical variables were analyzed for their potential impact on disease acquisition and severity. A total of 135 young people with CF were assessed from February 2020 until December 2022. Results: Eighty-four patients were infected with SARS-CoV-2, out of which nine patients reported re-infection, resulting in 93 SARS-CoV-2 infections. Most infections, 76/93 (82%), occurred during the period of omicron variant predominance. Higher body mass index and respiratory colonization with Haemophilus influenzae before the beginning of the pandemic were significantly associated with the risk of acquiring SARS-CoV-2 infection. All patients had an uncomplicated COVID-19 course, regardless of the SARS-CoV-2 variant and COVID-19 vaccine status at infection. The most frequent symptoms were rhinitis (53%), fatigue (49%), cephalea (43%), and fever (38%). Neither oxygen therapy nor hospitalization were needed for any of the patients. Lung function parameters (FEV1, FVC, FEF50, LCI), both in the early post-viral as well as late post-viral stages, were not significantly impacted by SARS-CoV-2 infections. No long-term post-COVID-19 effects were reported. Conclusions: Our single-centre experience suggests that the course of SARS-CoV-2 infections in children and adolescents with CF is primarily mild and uncomplicated.

17 November 2025 in Hormone Research in Paediatrics
Verified
Journal Article
Open access
RGRené Gaupmann
René Gaupmann
KSKlara Schmidthaler
Klara Schmidthaler
AKAida Korajac
Aida Korajac
KCKevin Cobb
Kevin Cobb
SGSaskia Gruber
Saskia Gruber
EDEleonora Dehlink
Eleonora Dehlink
Introduction: Bone health screening is established in cystic fibrosis (CF). Given the unknown status of bone quality in primary ciliary dyskinesia (PCD), these recommendations have not been adopted. We aimed to evaluate the bone phenotype in PCD compared to healthy controls and CF. Methods: In this exploratory cross-sectional study, we assessed bone mineral density (BMD) at the whole body and lumbar spine using dual-energy X-ray absorptiometry (DXA), and tibial bone microarchitecture using high-resolution peripheral quantitative computed tomography (HR-pQCT) in 15 individuals with PCD and 45 with CF, aged 12–20 years. Measures were compared to healthy controls matched one-to-one by pubertal stage and sex. Disease-to-healthy differences were compared between PCD and CF, and associations with body mass index (BMI), lean mass, and lung function were analysed. Results: DXA-measured areal BMD and HR-pQCT-derived total volumetric BMD showed no differences between PCD and controls. HR-pQCT revealed reduced cortical thickness, area, and BMD at the ultra-distal tibia in PCD compared to controls. While PCD and CF did not differ, the PCD bone phenotype more closely resembled pancreatic-insufficient than pancreatic-sufficient CF. Dimensional cortical deficits were largely explained by BMI or lean mass, especially in CF, but remained reduced in PCD after adjustment, indicating potentially intrinsic disease-related alterations. Lung function did not clearly correlate with bone outcomes in PCD. Conclusion: Skeletal health appears compromised in young people with PCD. Despite mostly normal densitometry, tibial bone microarchitecture was altered. This study positions bone health as a research priority in PCD and supports the need for larger confirmatory studies.

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
KSKlara Schmidthaler
Klara Schmidthaler
RGRené Gaupmann
René Gaupmann
MSMagda Diab-El Schahawi
Magda Diab-El Schahawi
BWBirgit Willinger
Birgit Willinger
ZSZsolt Szépfalusi
Zsolt Szépfalusi
EDEleonora Dehlink
Eleonora Dehlink
Introduction: Haemophilus influenzae is one of the most common airway pathogens in Primary Ciliary Dyskinesia (PCD). This study aimed to evaluate the effect of antibiotic treatment on H. influenzae airway colonization and the frequency of in-hospital cross-infections in a paediatric PCD cohort. Methods: In this prospective, single-centre, observational PCD cohort study, we aimed to illustrate the clonal relationship between different H. influenzae isolates from airway samples from consecutive outpatient visits between January 2020 and September 2021 by using Illumina whole-genome sequencing. Results: H. influenzae isolates from 15/33 PCD patients (13 females / 20 males, mean age 14.4 ± 6.1 years) were sequenced. The vast majority (13/15 patients) had more than one H. influenzae positive sample. Sequence-identical H. influenzae strains were detected in consecutive samples of 9/13 patients, although 4 patients had received targeted antibiotic treatment after the first isolate. New strains were detected in consecutive samples of 3 patients, all had been treated with antibiotics in the interim. One patient had a new strain after initial antibiotic treatment but regrew the first strain in a following sample. The two sibling pairs in our cohort did not have identical strains. Two unrelated patients had identical strains, which could indicate cross-infection within the hospital setting. Conclusion: Regrowth of identical H. influenzae strains is common despite targeted antibiotic treatment. In hospital cross-infection was rare in our paediatric PCD cohort. These findings need to be confirmed in a larger cohort, e.g. within the network of the Beat-PCD clinical research collaboration.